Protara Therapeutics Inc

TARANASDAQ · USD
3.21USD-0.04 (-1.24%)
227

Protara Therapeutics Inc (TARA) Covered Calls

As of September 28, 2026, TARA has 2 covered call opportunities in the coming three months. Return ranges from 54.0 to 57.0% until expiration. Annualized return ranges from 141.6 to 351.7%. The nearest expiration is November 20, 2026. Maximum potential profit is $187.

Read more

Running TARA covered calls helps you generate consistent income from Protara Therapeutics Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Protara Therapeutics Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best TARA covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if TARA stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling TARA covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Protara Therapeutics Inc covered call is worth writing.

Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease. The company was formerly known as ArTara Therapeutics, Inc. and changed its name to Protara Therapeutics, Inc. in May 2020.

Protara Therapeutics, Inc. is headquartered in New York, New York.

Income-focused investors, long-term TARA holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling TARA covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Protara Therapeutics Inc covered calls come to you, already filtered for the metrics that matter.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile91.27% Elevated
  • Market cap (M$)192
  • 52 weeks high-58.44%
  • 52 weeks low0.62%
  • Analyst recommendationStrong Buy
    1.00
  • Target price$25.71
    700.93% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2026-11-09
  • P/E—
  • Future P/E—
  • EPS (ttm)-1.35
  • EPS growth next 5 years23.07%

As of September 28, 2026

2026-11-20565.0052.440.050.10177.0053.96351.73-1.52+0.151,0220.05
2027-02-191475.0052.440.150.45187.0057.01141.56-4.57+0.333820.30

As of September 28, 2026

Sell covered calls with the data behind you

Find the best TARA covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.

Start your 14-day free trial